Your browser doesn't support javascript.
loading
Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study.
Elsherif, Laila; Scott, Lara C; Wichlan, David; Jones, Susan K; Mathias, Joacy G; Shen, Jessica H; Smeltzer, Matthew P; Ataga, Kenneth I.
Afiliação
  • Elsherif L; Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Scott LC; College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Wichlan D; Division of Hematology, University of North Carolina, Chapel Hill, NC, USA.
  • Jones SK; Division of Hematology, University of North Carolina, Chapel Hill, NC, USA.
  • Mathias JG; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
  • Shen JH; Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
  • Smeltzer MP; Division of Hematology, University of North Carolina, Chapel Hill, NC, USA.
  • Ataga KI; School of Dentistry, Temple University, Philadelphia, PA, USA.
Br J Haematol ; 194(3): e71-e73, 2021 08.
Article em En | MEDLINE | ID: mdl-34231209
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coagulação Sanguínea / Hidroxiureia / Anemia Falciforme / Antidrepanocíticos Tipo de estudo: Observational_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coagulação Sanguínea / Hidroxiureia / Anemia Falciforme / Antidrepanocíticos Tipo de estudo: Observational_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article